Cytotoxic cell involvement in human cutaneous leishmaniasis: Assessments in active disease, under therapy and after clinical cure

Parasite Immunology

Volumn 38, Issue 4, 2016, Pages 244-254

  Cunha, C F ^a   Ferraz, R ^a   Pimentel, M I F ^b   Lyra, M R ^b   Schubach, A O ^b   Da Cruz, A M ^a   Bertho, A L ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

CD107a; Cytotoxic T cells; Flow cytometry; Human cutaneous leishmaniasis; NK cells; NKT cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LEISHMANIA BRAZILIENSIS; MALE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN LEISHMANIASIS; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CYTOTOXICITY; DEGRANULATION; IMMUNOLOGY; LEISHMANIASIS, CUTANEOUS; MIDDLE AGED; NATURAL KILLER CELL; PARASITOLOGY; YOUNG ADULT;

ADULT; ANTIPROTOZOAL AGENTS; CD4 LYMPHOCYTE COUNT; CELL DEGRANULATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; KILLER CELLS, NATURAL; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; NATURAL KILLER T-CELLS; ORGANOMETALLIC COMPOUNDS; YOUNG ADULT;

EID: 84961918633     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12312     Document Type: Article

References (49)

1. WHO|Leishmaniasis [Internet]. WHO. [cited 2015 Mar 25]. Available from: http://www.who.int/mediacentre/factsheets/fs375/en/.
2. De Oliveira-Neto MP, Mattos MS, Perez MA, et al. American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics. Int J Dermatol 2000; 39: 506-514.
3. Brelaz-de-Castro MCA, de Almeida AF, de Oliveira AP, de Assis-Souza M, da Rocha LF & Pereira VRA. Cellular immune response evaluation of cutaneous leishmaniasis patient cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure. Cell Immunol 2012; 279: 180-186.
4. Kaye P & Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 2011; 9: 604-615.
5. Novais FO & Scott P. CD8(+) T cells in cutaneous leishmaniasis: the good, the bad, and the ugly. Semin Immunopathol 2015; 37: 251-259.
6. + T cells associated with cure of human cutaneous leishmaniasis. Infect Immun 1994; 62: 2614-2618.
7. Da-Cruz AM, Bittar R, Mattos M, et al. T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clin Diagn Lab Immunol 2002; 9: 251-256.
8. Da-Cruz AM, Bertho AL, Oliveira-Neto MP & Coutinho SG. Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions. Br J Dermatol 2005; 153: 537-543.
9. Coutinho SG, Da-Cruz AM, Bertho AL, Santiago MA & De-Luca P. Immunologic patterns associated with cure in human American cutaneous leishmaniasis. Braz J Med Biol Res 1998; 31: 139-142.
10. Bittar RC, Nogueira RS, Vieira-Gonçalves R, et al. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis. Mem Inst Oswaldo Cruz 2007; 102: 625-630.
11. + cells from lesions of patients with localized cutaneous leishmaniasis. Braz J Med Biol Res 2000; 33: 317-325.
12. + T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy. BMC Infect Dis 2015; 15: 74.
13. Machado P, Kanitakis J, Almeida R, Chalon A, Araújo C & Carvalho EM. Evidence of in situ cytotoxicity in American cutaneous leishmaniasis. Eur J Dermatol 2002; 12: 449-451.
14. Faria DR, Souza PEA, Durães FV, et al. Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol 2009; 31: 432-439.
15. Santos Cda S, Boaventura V, Ribeiro Cardoso C, et al. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol 2013; 133: 1533-1540.
16. Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998; 282: 121-125.
17. Aranha FCS, Ribeiro U Jr, Basse P, Corbett CEP & Laurenti MD. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection. Scand J Immunol 2005; 62: 334-341.
18. Lieke T, Nylén S, Eidsmo L, Schmetz C, Berg L & Akuffo H. The interplay between Leishmania promastigotes and human Natural Killer cells in vitro leads to direct lysis of Leishmania by NK cells and modulation of NK cell activity by Leishmania promastigotes. Parasitology 2011; 9: 1-12.
19. Ishikawa H, Hisaeda H, Taniguchi M, et al. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 2000; 12: 1267-1274.
20. Joyee AG, Uzonna J & Yang X. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection. J Immunol Baltim Md 1950 2010; 184: 2095-2106.
21. Brown DM. Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell Immunol 2010; 262: 89-95.
22. Naouar I, Boussoffara T, Ben Ahmed M, et al. Involvement of different CD4(+) T cell subsets producing granzyme B in the immune response to Leishmania major antigens. Mediators Inflamm 2014; 2014: 636039.
23. Lopez JA, Brennan AJ, Whisstock JC, Voskoboinik I & Trapani JA. Protecting a serial killer: pathways for perforin trafficking and self-defence ensure sequential target cell death. Trends Immunol 2012; 33: 406-412.
24. Aktas E, Kucuksezer UC, Bilgic S, Erten G & Deniz G. Relationship between CD107a expression and cytotoxic activity. Cell Immunol 2009; 254: 149-154.
25. SVS, Ministério da Saúde. Manual de Vigilância da Leishmaniose Tegumentar Americana [Internet]. 2010 [cited 2012 Nov 13]. Available from: http://portal.saude.gov.br/portal/arquivos/pdf/manual2_lta_2ed.pdf.
26. + T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65-78.
27. + T cells in Leishmania braziliensis infection. Infect Immun 2015; 83: 898-906.
28. Da Silva Santos C & Brodskyn CI. The role of CD4 and CD8T cells in human cutaneous leishmaniasis. Front Public Health 2014; 2: 165.
29. + T cells in patients with American cutaneous leishmaniasis. Clin Exp Immunol 2012; 167: 505-513.
30. Coutinho SG, Oliveira MP, Da-Cruz AM, et al. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure. Exp Parasitol 1996; 84: 144-155.
31. Toledo VP, Mayrink W, Gollob KJ, et al. Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment. Mem Inst Oswaldo Cruz 2001; 96: 89-98.
32. Novais FO, Carvalho LP, Graff JW, et al. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog 2013; 9: e1003504.
33. Maretti-Mira AC, Bittner J, Oliveira-Neto MP, et al. Transcriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans. PLoS Negl Trop Dis 2012; 6: e1816.
34. Carvalho AM, Magalhães A, Carvalho LP, Bacellar O, Scott P & Carvalho EM. Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis. BMC Infect Dis 2013; 13: 529.
35. Trautmann A, Rückert B, Schmid-Grendelmeier P, et al. Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation. Immunology 2003; 108: 305-312.
36. Bajénoff M, Breart B, Huang AYC, et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 2006; 203: 619-631.
37. Cañeda-Guzmán IC, Salaiza-Suazo N, Fernández-Figueroa EA, Carrada-Figueroa G, Aguirre-García M & Becker I. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines. PLoS One 2014; 9: e112410.
38. Laouar Y, Sutterwala FS, Gorelik L & Flavell RA. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 2005; 6: 600-607.
39. Maroof A, Beattie L, Zubairi S, Svensson M, Stager S & Kaye PM. Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity 2008; 29: 295-305.
40. Cooper MA, Fehniger TA & Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-640.
41. Inngjerdingen M, Kveberg L, Naper C & Vaage JT. Natural killer cell subsets in man and rodents. Tissue Antigens 2011; 78: 81-88.
42. Griewank KG, Lorenz B, Fischer MR, Boon L, Lopez Kostka S & von Stebut E. Immune modulating effects of NKT cells in a physiologically low dose Leishmania major infection model after αGalCer analog PBS57 stimulation. PLoS Negl Trop Dis 2014; 8: e2917.
43. Bendelac A, Savage PB & Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336.
44. + double-positive T cells: more than just a developmental stage? J Leukoc Biol 2015; 97: 31-38.
45. +, CD8α+ and CD4-CD8α- invariant natural killer T cells. PLoS One 2011; 6: e28648.
46. Montoya CJ, Pollard D, Martinson J, et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 2007; 122: 1-14.
47. Gumperz JE, Miyake S, Yamamura T & Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002; 195: 625-636.
48. Carvalho KI, Melo KM, Bruno FR, et al. Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID). PLoS One 2010; 5: e12652.
49. Kumari S, Jamal F, Shivam P, et al. Leishmania donovani skews the CD56(+) natural killer T cell response during human visceral leishmaniasis. Cytokine 2015; 73: 53-60.